New features of glatiramer acetate for the treatment of remitting multiple sclerosis

The article discusses usage of the new dosage of glatiramer acetate (Copaxone®) for the treatment of relapsing-remitting multiple sclerosis. Results of phase II and III clinical trials are presented. Randomized clinical trials GALA and GLACIER demonstrated high efficacy, good safety and tolerability...

Descrizione completa

Dettagli Bibliografici

Autore principale:	N. Y. Lasch
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	Remedium Group LLC 2015-12-01
Serie:	Медицинский совет
Soggetti:	рассеянный склероз препараты изменяющие течение рассеянного склероза (питрс) глатирамера ацетат multiple sclerosis multiple sclerosis disease-modifying medications (msdmm) glatiramer acetate
Accesso online:	https://www.med-sovet.pro/jour/article/view/273
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!